-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Using Direct Oral Anticoagulants in Cancer and Other High-Risk Populations

Program: Education Program
Session: Evolving Issues in Anticoagulation
Saturday, December 5, 2015, 4:00 PM-5:30 PM
Tangerine 1 (WF1), Level 2 (Orange County Convention Center)
Sunday, December 6, 2015, 7:30 AM-9:00 AM
Tangerine 1 (WF1), Level 2 (Orange County Convention Center)

Harry Roger Büller, MD, PhD

Dept of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands

Disclosures: No relevant conflicts of interest to declare.

See more of: Evolving Issues in Anticoagulation
See more of: Education Program
<< Previous Presentation | Next Presentation